Clinical Trials on Endometriosis, Adhesive in Canada

Total 57 results

McMaster University

Enrolling by invitation

Combining Ultrasound and Biomarkers to Diagnose Superficial Endometriosis (SPGENDO)

Endometriosis | Endometriosis (Diagnosis)

Canada
Queen's University

Completed

An RCT in Treatment of Adhesive Capsulitis Arthrographic Joint Distention With Local Anesthetic Alone

Adhesive Capsulitis

Canada
Enteris BioPharma Inc.
Syneos Health

Completed

A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers

Endometriosis

Canada
Dr. Robert F. Casper

Withdrawn

Statins: A New Therapeutic Option for Treatment of Patients With Endometriosis

Endometriosis

Canada
Istanbul University

Completed

Assessment of Telomerase Activity in Endometrial Tissue and Serum in Endometriosis Patients

Infertility, Female | Endometriosis Ovaries

Turkey
BC Women's Hospital & Health Centre
BC Support Unit

Completed

Endocation: Trial of an Endometriosis Education Program

Endometriosis

Canada
Western University, Canada

Unknown

Physiotherapy Program for Managing Adhesive Capsulitis in Patients With Diabetes

Diabetes Mellitus | Adhesive Capsulitis

Canada
University of British Columbia

Unknown

The Efficacy of Cyanoacrylate Adhesive (PeriAcryl®90 HV) in Periodontal Wound Healing

Pain | Periodontal Disease | Wound Healing | Tissue Adhesive | Dental Scaling | Oral Surgical Procedures

Canada
BC Women's Hospital & Health Centre

Completed

Pathways for Patient-centered Diagnosis and Management of Endometriosis-associated Deep Dyspareunia

Endometriosis-related Pain | Dyspareunia Deep

Canada
Myovant Sciences GmbH

Completed

SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

Endometriosis Related Pain

United States, Spain, Hungary, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Poland, Portugal, South Africa, Ukraine
AbbVie

Completed

Real-World Experience Study of Elagolix For the Treatment of Endometriosis in Canada (GRACE)

Endometriosis

Canada
BC Women's Hospital & Health Centre

Completed

Dyspareunia and Central Sensitization

Endometriosis | Dyspareunia | Central Sensitisation

Canada
BC Women's Hospital & Health Centre
The Swedish Research Council

Active, not recruiting

Endometriosis and Health Care System Utilization in British Columbia (EndoCare)

Endometriosis

Canada
McGill University Health Centre/Research Institute...

Not yet recruiting

Estetrol/Drospirenone to Reduce the Average Size of Endometriomas (ERASE)

Endometrioma | Ovarian Endometrioma

Canada
Dr. Caroline Pukall

Recruiting

Investigating the Effectiveness of PelvicSense(R) on Pain and Sexual Outcomes in Endometriosis

Endometriosis

Canada
McMaster University
Hamilton Health Sciences Corporation

Enrolling by invitation

The Role of a Mediterranean Diet in Patients With Endometriosis: a Feasibility Trial (MDIE)

Endometriosis

Canada
University of Ottawa

Recruiting

Is Repetitive Transcranial Magnetic Stimulation Effective in Reducing Endometriosis-associated Pain

Pain | Endometriosis

Canada
Bayer

Terminated

Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis (VILLENDO)

Endometriosis

United States, Austria, Japan, Poland, Finland, Canada, Italy, Czechia
BC Women's Hospital & Health Centre
University of British Columbia

Not yet recruiting

Quantitative Sensory Testing and Central Sensitization in Endometriosis

Pain | Endometriosis

Canada
Universidad de Granada

Completed

Effect of a Rehabilitation Program to Improve Quality of Life in Women Diagnosed With Endometriosis (Physio-EndEA Study) (Physio-EndEA)

Endometriosis

Spain
University of Calgary

Not yet recruiting

The Efficacy of a Topical Anti-adhesive Film for Decreasing Perihepatic Adhesions in Repeat Hepatic Surgery

Liver Neoplasms | Adhesion

Canada
Hyivy Health Inc
McMaster University

Not yet recruiting

Hyivy Device in Endometriosis (endometriosis)

Endometriosis | Pelvic Pain

Canada
Unity Health Toronto

Completed

Virtual Mindfulness for the Management of Endometriosis Pelvic Pain.

Chronic Pain | Endometriosis

Canada
BC Women's Hospital & Health Centre
Canadian Institutes of Health Research (CIHR); UBC Department of Obstetrics...

Enrolling by invitation

Endometriosis Pelvic Pain Interdisciplinary Cohort Data Registry (EPPIC)

Endometriosis

Canada
Lumara Health, Inc.

Completed

Pain Associated With Endometriosis

Endometriosis

United States, Russian Federation, Canada
Kissei Pharmaceutical Co., Ltd.

Terminated

Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 5)

Endometriosis

United States, Canada, Puerto Rico
Clinique Ovo

Completed

Chronic Endometritis in Patients With Recurrent Miscarriages or Repeated Implantation Failures in In-vitro Fertilization

Infertility | Abortion, Spontaneous | Endometritis

Canada
McGill University Health Centre/Research Institute...

Withdrawn

Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids (eTAPE)

Endometriosis | Fibroids

Canada
Angiotech Pharmaceuticals

Completed

Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation

Myoma

Canada, Germany, Netherlands Antilles
ZIWIG
Monitoring Force Group; iGenSeq

Active, not recruiting

Multicenter Validation of the Salivary miRNA Signature of Endometriosis

Endometriosis

France, Canada
ObsEva SA

Terminated

A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain

Endometriosis

United States, Canada, Puerto Rico
Lawson Health Research Institute

Active, not recruiting

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

Carcinosarcoma | Endometrioid Adenocarcinoma | Clear Cell Carcinoma | Serous Carcinoma | Dedifferentiated Carcinoma

Canada
University Health Network, Toronto

Withdrawn

Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Endometrioid Tumor | TP53 Mutation

Canada
Saint Thomas Hospital, Panama
Sistema Nacional de Investigación (SNI) - Panamá

Completed

Use of Antiseptic Solution for Vaginal Wash Before Cesarean Section

Endometritis | Operation Wound; Infection

Panama
National Cancer Institute (NCI)

Active, not recruiting

Bevacizumab and Anetumab Ravtansine or Paclitaxel in Treating Patients With Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Endometrioid Adenocarcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Ovarian High Grade Serous Adenocarcinoma | Platinum-Resistant... and other conditions

United States, Canada
Bayer

Completed

Bay98-7196, Dose Finding / POC Study

Endometriosis

Belgium, Finland, Switzerland, Germany, Spain, Japan, United States, Canada, Austria, Czechia, Denmark, Netherlands, Poland, Norway
University Health Network, Toronto
GlaxoSmithKline

Recruiting

Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitor

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | High Grade Serous Cancer | High Grade Endometrioid Cancer

Canada
University of British Columbia
Genzyme, a Sanofi Company

Terminated

Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemotherapy for Advanced Ovarian Cancer

Epithelial Ovarian Cancer

Canada, United States
Bayer

Terminated

Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb (SCHUMANN)

Endometriosis

Spain, Belgium, United States, Germany, Austria, Japan, Canada, Hungary, Bulgaria, Italy, China, Czechia, Finland, Norway, Poland, Slovakia, Estonia, Greece, Latvia, Lithuania
AbbVie

Completed

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

Endometriosis

United States, Canada, Puerto Rico
Myovant Sciences GmbH

Completed

SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

Endometriosis

United States, Spain, Argentina, Belgium, Bulgaria, Canada, Czechia, Finland, Hungary, Poland, Portugal, South Africa, Ukraine, Australia, Brazil, Chile, Italy, New Zealand, Romania, Georgia
National Cancer Institute (NCI)

Completed

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Uterine Carcinosarcoma | Recurrent Uterine Corpus Carcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Adenocarcinoma | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7 | Uterine Corpus Carcinosarcoma

United States, Canada
GOG Foundation
National Cancer Institute (NCI)

Active, not recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Recurrent Endometrial Clear Cell Adenocarcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Recurrent Endometrial Serous Adenocarcinoma | Recurrent Endometrial Undifferentiated Carcinoma | Recurrent Uterine Corpus Cancer | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell... and other conditions

United States, Canada
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

Endometriosis | Dysmenorrhea | Pelvic Pain | Dyspareunia

Hong Kong, United States, Canada, Australia, United Kingdom, South Africa, Belgium
National Cancer Institute (NCI)

Active, not recruiting

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Endometrial Clear Cell Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Recurrent Uterine Corpus Cancer | Stage IV Uterine Corpus Cancer AJCC v7 | Stage IVA Uterine Corpus Cancer AJCC v7 | Stage IVB Uterine Corpus Cancer AJCC v7 | Endometrial Adenosquamous... and other conditions

United States, Canada
National Cancer Institute (NCI)

Active, not recruiting

Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated Carcinoma | Ovarian... and other conditions

United States, Canada, Singapore
Medical College of Wisconsin
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaborators

Completed

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204) (RICHI)

Chronic Granulomatous Disease | Hemophagocytic Lymphohistiocytosis | Leukocyte Adhesion Deficiency | Chronic Active Epstein-Barr Virus Infection | HIGM-1 | IPEX

United States, Canada
National Cancer Institute (NCI)
AstraZeneca; NRG Oncology

Active, not recruiting

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditions

United States, Canada, Korea, Republic of, Japan
National Cancer Institute (NCI)
NRG Oncology; Canadian Cancer Trials Group

Active, not recruiting

Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer

Endometrial Clear Cell Adenocarcinoma | Endometrial Dedifferentiated Carcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Recurrent Endometrial Adenocarcinoma | Recurrent Endometrial... and other conditions

United States, Korea, Republic of, Canada, Puerto Rico, Japan
National Cancer Institute (NCI)
NRG Oncology; Canadian Cancer Trials Group

Active, not recruiting

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditions

United States, Canada, Puerto Rico, Korea, Republic of, Japan

Clinical Trials on Endometriosis, Adhesive in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations